Benzonatate Capsule
Product Images NDC 67296-2194

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 67296-2194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Benzo-cap-100mg (Benzo Cap 100mg)

This is a description for Benzonatate capsules USP containing 100 mg each. The capsules should be swallowed whole and not broken, chewed, dissolved, cut, or crushed. They should be stored at 20-25°C and protected from light. The usual dosage should be determined by consulting the package insert for complete prescribing information. The manufacturer is CSPC-NEP PHARMACEUTICAL CO., LTD and the distributor is Rising Pharma Holdings, Inc.*

FDA Label Image

Benzo-cap-200mg (Benzo Cap 200mg)

This is a description of Benzonatate Capsules USP, which contain 200 mg of Benzonatate. The capsules should be stored at 20-25°C (68-77°F) and protected from light. It is recommended to swallow the capsules whole and not break, chew, dissolve, cut, or crush them. The medication should be dispensed in a light-resistant container as defined in the USP. The manufacturer is CSPC-NEP PHARMACEUTICAL CO.LTD in China. The distributor is Rising Pharma Holdings, Inc. located in East Brunswick. Dosage information can be found in the package insert.*

FDA Label Image

Chemical Structure (Benzonatate 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.